Pharmerica (PMC) Reports In-Line Q2 EPS

Pharmerica (NYSE: PMC) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $519.6 million versus the consensus estimate of $508.31 million.Pharmerica reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c